Tharimmune granted patent for delivery of molecularly targeted therapeutics
Tharimmune (THAR) announced that the European Patent Office intends to grant the Company a patent covering biodegradable polymeric ...
Dallas Innovates9h
Patented: Verily Life Sciences’ Eye-Mountable Therapeutic Devices and More North Texas Inventive Activity
Abstract: Systems, eye-mountable devices, and methods that facilitate chronotherapeutic treatment of primary open-angle ...
Tharimmune Granted European Patent for Delivery of Optimized Molecularly Targeted Therapeutics
Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...
Energy Central20h
Moody's Rating adds telecoms, airlines, utilities to highest risk category
IMO, this was inevitable as the digitalization of energy infrastructure rapidly expands as the energy transition rolls on. You can't put 1000's of "smart devices" on the grid, which are all running ...